Prognostic Factors for Permanent Work Disability in Patients With Rheumatoid Arthritis Who Received Combination Therapy of Conventional Synthetic Disease-Modifying Antirheumatic Drugs-Reference-Cited by-同舟云学术

Prognostic Factors for Permanent Work Disability in Patients With Rheumatoid Arthritis Who Received Combination Therapy of Conventional Synthetic Disease-Modifying Antirheumatic Drugs

Published:2017-10 Issue:7 Volume:23 Page:376-382
ISSN:1076-1608
Container-title:JCR: Journal of Clinical Rheumatology
language:en
Short-container-title:JCR: Journal of Clinical Rheumatology

Author:

Vazquez-Villegas M. Luisa,Gamez-Nava Jorge I.,Celis Alfredo,Sanchez-Mosco Dalia,de la Cerda-Trujillo Liliana F.,Murillo-Vazquez Jessica D.,Saldaña-Cruz A. Miriam,Alcaraz-Lopez Miriam F.,Diaz-Rizo Valeria,Alvarez-Nemegyei Jose,Cardiel Mario H.,Gonzalez-Lopez Laura

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Rheumatology

Reference28 articles.

1. Epidemiology of rheumatic diseases

2. Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study

3. Employment and work disability in rheumatoid arthritis

4. High work disability rate among rheumatoid arthritis patients in Lithuania

5. Sick leave as a predictor of job loss in patients with chronic arthritis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Employment of patients with rheumatoid arthritis - a systematic review and meta-analysis;BMC Rheumatology;2023-11-14

2. Risk Factors of Muscle Wasting in Women with Rheumatoid Arthritis: Relevance of the Persistent Failure of Conventional Combination Therapy;Healthcare;2022-10-11

3. Work disability and rheumatoid arthritis: Predictive factors;Work;2021-08-27

4. Predictors of sick leave and improved worker productivity after 52 weeks of intensive treatment in patients with early rheumatoid arthritis;Scandinavian Journal of Rheumatology;2019-05-28

5. Outcomes after rheumatoid arthritis patients complete their participation in a long-term observational study with tofacitinib combined with methotrexate: practical and ethical implications in vulnerable populations after tofacitinib discontinuation;Rheumatology International;2017-12-20